2021 CareChex Awards Released for Top Performing Healthcare Organizations

GREENVILLE, SC – Quantros, a leading provider of quality analytics software to healthcare providers and purchasers, has released their annual CareChex® Awards. These awards celebrate the accomplishments of hospitals and health systems across the nation in specific clinical categories.

Quantros has been helping hospitals leverage their data into clear insights and actionable improvements for decades, allowing patients to feel confident in choosing a hospital differentiated with a CareChex® award.

2021 CareChex® awards use CMS data from October 2016 to September of 2019 and are based on Quantros’ proprietary scoring system which compares inpatient performance across general, acute, non-federal US hospitals.

Quantros prides itself in providing the most comprehensive and objective calculation of hospital and health system quality performance in the industry:

  • Our vast datasets allow for accurate benchmarking and risk-adjustment
  • No self-reported or survey data is included
  • CareChex® awards are not “pay-to-play,” all general, acute, non-federal hospitals within the US are included
  • Results are tested for statistical significance, resulting in clearer, more accurate performance differentiation across 39 clinical categories in both Medical Excellence and Patient Safety.

Why is CareChex® by Quantros superior to other quality rating methods?

CareChex Awards by Quantros utilizes a peer-reviewed risk-adjustment methodology to more reliably measure rates of mortality, complications and readmissions — appropriately weighting and accounting for all of the risk factors relating to a patient’s principal and secondary diagnosis, as well as other patient characteristics that may increase the probability for adverse clinical outcomes. These rankings do not include any self-reported data.

If you are interested in if your organization earned awards, click here to request your 2021 award summary.

Follow us on social media for the latest updates in B2B!


BioTech Startups Want to Revive Failed Medicines to Create New Lifesaving Treatments
Behind the Clinical Trials for Non-Alcohol Fatty Liver Disease that Can Benefit 30% of Americans
July 1, 2022
  The Impact Research Institute (IRI) is Waco, Texas’ resource for extending care options for NAFLD (non-alcohol fatty liver disease.) Nadege Gunn is IRI’s Medical Director and President. She Read more
FABTECH Show Kickoff and Overview of Solutions Distributed by DeGeest
June 30, 2022
This is another episode of Manufacturing A Stronger Standard live from FABTECH 2021. Host and President of LestaUSA and DeGeest Corp., Derek DeGeest, talked with Brad Ruppert, Engineering Manager, and Read more
Improving Quality and Bottomline for Finishing Operations
June 30, 2022
This is another episode of Manufacturing A Stronger Standard from FABTECH 2021. Host and President of Lesta USA and Degeest Corp., Derek Degeest, talked with Bill Robinson, President and Kris Bonnegent, Regional Read more